- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03555344
Effect of Mantra on Hypertensive Patients
July 14, 2018 updated by: NMP Medical Research Institute
Immediate Effect of Mantra Chikitsa on Cardiovascular Parameters in Hypertensive Patients
Mantras are specialized energized sound or words, which are defined most important sound therapy in Vedic healing.
Present study was undertaken to evaluate the immediate effect of specialized Mantra chant on cardiovascular parameters in high blood pressure patients.
Study Overview
Study Type
Interventional
Enrollment (Actual)
96
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Rajasthan
-
Jaipur, Rajasthan, India, 302019
- NMP Medical Research Institute
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 56 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Diagnosed and stable hypertension
- on regular medication
Exclusion Criteria:
- Individuals diagnosed with another lung disease,
- Have psychiatric, musculoskeletal or cardiovascular diseases,
- Being smokers
- Being pregnant
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Mantra Chikitsa
Mantra chanting for 15 mins
|
Specific Mantra were given to chants for 15 mins and resting in the impact of chants for following 15 mins.
Other Names:
|
|
No Intervention: Wait list control
Rest for 15 Mins
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Systolic Blood Pressure
Time Frame: Change from baseline to half an hour
|
Change from baseline to half an hour
|
|
Diastolic Blood Pressure
Time Frame: Change from baseline to half an hour
|
Change from baseline to half an hour
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Supine heart rate (HR)
Time Frame: Change from baseline to half an hour
|
Change from baseline to half an hour
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ravishankar Ramanathan, Swamigal Trust for Vedic Science, India
- Study Chair: Puneet Sharma, NMP Medical Research Institute
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 28, 2017
Primary Completion (Actual)
May 15, 2018
Study Completion (Actual)
May 30, 2018
Study Registration Dates
First Submitted
June 1, 2018
First Submitted That Met QC Criteria
June 1, 2018
First Posted (Actual)
June 13, 2018
Study Record Updates
Last Update Posted (Actual)
July 17, 2018
Last Update Submitted That Met QC Criteria
July 14, 2018
Last Verified
June 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NMP/10164
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.